CNRWX
Price
$25.89
Change
+$0.21 (+0.82%)
Updated
Aug 8 closing price
Net Assets
373.36M
VSTSX
Price
$300.02
Change
+$1.99 (+0.67%)
Updated
Aug 8 closing price
Net Assets
1.91T
Interact to see
Advertisement

CNRWX vs VSTSX

Header iconCNRWX vs VSTSX Comparison
Open Charts CNRWX vs VSTSXBanner chart's image
City National Rochdale US Cor Eq N
Price$25.89
Change+$0.21 (+0.82%)
VolumeN/A
Net Assets373.36M
Vanguard Total Stock Mkt Idx Instl Sel
Price$300.02
Change+$1.99 (+0.67%)
VolumeN/A
Net Assets1.91T
CNRWX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CNRWX vs. VSTSX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNRWX is a Buy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. CNRWX (373M). VSTSX pays higher dividends than CNRWX: VSTSX (1.20) vs CNRWX (0.05). CNRWX was incepted earlier than VSTSX: CNRWX (13 years) vs VSTSX (9 years). CNRWX (1.07) is less costly to investors than VSTSX (0.01). CNRWX is a more actively managed with annual turnover of: 20.00 vs. VSTSX (2.00). CNRWX has a lower initial minimum investment than VSTSX: CNRWX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 19.70 vs. CNRWX (-2.30). VSTSX return over 5 years is better than : 85.11 vs. CNRWX (26.83).
CNRWXVSTSXCNRWX / VSTSX
Total Expense Ratio1.070.0110,700%
Annual Report Gross Expense Ratio1.070.0110,700%
Fund Existence13 years9 years-
Gain YTD6.5158.08881%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets373M1.91T0%
Annual Yield % from dividends0.051.204%
Returns for 1 year-2.3019.70-12%
Returns for 3 years10.0952.0519%
Returns for 5 years26.8385.1132%
Returns for 10 years91.30N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACT11.400.01
+0.09%
Ares Acquisition Corp
MOLN3.66N/A
N/A
Molecular Partners AG
IEX158.26-0.27
-0.17%
IDEX Corp
LYRA6.70-0.19
-2.76%
Lyra Therapeutics Inc
HCM15.00-1.31
-8.03%
HUTCHMED (China) Limited